More Information on 'Cytena GmbH'

Cytena GmbH is a company specializing in liquid handling and single-cell dispensing solutions. Their products and services cater to the life sciences industry, particularly in the areas of cell line development, cell therapy, and single-cell omics. Founded in 2014, Cytena has developed the LiquidBiopsy rare cell isolation platform, which enables researchers to analyze and understand circulating tumor cells. The company's applications include anaerobic cell isolation, cell line development, cell therapy, and gene therapy, among others. By providing innovative solutions, Cytena supports scientists in their quest for better understanding and treatment of diseases.

About Cytena GmbH
All began in summer 2014, when three young entrepreneurs started CYTENA out of the laboratory for MEMS applications and Hahn-Schickard. The first year ended quite successful with already the first single-cell printer sold to a big German company. In the following year 2015 CYTENA raised first venture capital from European investors in their successful seed round. We are so excited to have sold our instruments to so many customers world-wide and so far, most of the worlds biggest pharma companies use our instruments in their cell line development workflows. Since August 2019 we are a proud and happy part of the CELLINK family and we are on the road of success constantly looking for new team members.